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CASE DESCRIPTION 
A 45-year-old African-American male was admitted to the 
hospital complaining of back and chest discomfort and 
general malaise of 4 days’ duration. He also reported 
unquantified weight loss, occasional low-grade fever, 
drenching night sweats, productive cough, whitish expec- 
toration, and pleuritic chest pain. He denied headache, 
vomiting, diarrhea, dysuria, and abdominal pain. 
The married father of six children, he was a former 
crack user, moderate smoker, nonalcoholic known to have 
acquired immunodeficiency syndrome (AIDS), on the 
basis of CD4 cell count of 5&L, done 3 months before 
admission. His tuberculin test (PPD) result had been aner- 
gic 2 weeks previously. He denied any history of heart dis- 
ease, diabetes, hypertension, or drug allergies. He was 
born and raised in New York and had no travel history. 
When the paramedics arrived at his house, they 
found him lying on his bed, and saying, “I might as well 
go to the hospital.” He told them he was out of his med- 
ications, and he did not know their names. Vital signs 
were recorded as follows: blood pressure (BP) 116/72; 
pulse rate (PR) 80, regular; respiration rate (RR) 16; and 
Gkisgow Coma scale, 15. 
In the emergency department, the patient’s temperature 
was 966°F (3588°C); PR 78; RR 16; and BP 1 lOnO. He was 
noted to have poor oral hygiene, and tender lumbar verte- 
brae 1 - 5. No gross abnormality was found on examination 
of respiratory, cardiovascular, and gastrointestinal systems. 
Preliminary laboratory results showed 
White blood cell count (W’BC): 5.7 X 109/L 
Neutrophils: 3 1% 
Lymphocytes: 58% 
Bands: l’% 
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Eosinophils: 7% 
Monocytes: 3% 
Hematocrit: 0.28 
Platelet count: 427 X 109/L 
Mean corpuscular volume (MCV): 85.2 fL 
Glucose: 9.38 mmol/L 
Blood urea nitrogen (BUN): 7.49 mmol/L 
Creatinine serum: 137.25 umol/dL 
Sodium (Na+): 138.9 mmol/L 
Potassium (K+): 4.02 mmol/L 
Carbon dioxide (CO,): 2 1.3 mmol/L 
Aspartate aminotransferase (AST): 23 IU/L 
Alanine aminotransferase (ALI’): 18 IU/L 
Thyroid panel (TP): 67 g/L 
Calcium (Ca++): 2.02 mmol/L 
Magnesium (Mg++): 0.61 mmol/L 
Total bilirubin: 8.55 umol/L 
Arterial blood gases (ABG) on room oxygen (0,): pH 
7.40; PO, = 6.43 kPa; Pco, = 4.25 kPa; oxygen satu- 
ration = 84.3% 
Lumbar spine radiograph: normal 
Chest radiograph: cardiomegaly, no parenchymal infil- 
tration nor consolidation; the left costophrenic recess 
was slightly blunted; the hemidiaphragms were sharp; 
perivascular cuffing was evident with prominent pul- 
monary vascular shadows; the cardiac silhouette was 
enlarged in size, shape, and configuration, consistent with 
cardiomegaly; radiographic signs suggestive of congestive 
heart failure were noted; the tracheobronchial tree was 
midline and patent (Figure 1). 
Electrocardiogram: normal sinus rhythm (NSR) = 
98/min, normal electrical axis, normal intervals, and no 
acute sinus tachycardia (ST) changes. 
The patient was admitted to the medical ward where 
physical examination revealed 
Vital signs: temp 96°F (35.55”C); PR 78, regular; RR 
16; BP 1 lo/70 
Ill-looking middle-aged man, in no acute distress; 
pupils 3 mm in size, equally reactive 
Bilateral bronchial breath sounds, fine basal rales 
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Point of maximal impulse (PMI) in fifth costal inter- 
space 
Heart sound: only Sl and S2 were heard, regular, with- 
out murmur, rub or gallop 
Old abdominal scar of childhood injury 
Abdomen was flat, soft, nontender without 
hepatosplenomegaly or palpable masses 
Swollen glans penis, ulcerative lesion of 3 cm in diam- 
eter at the base of the phallus 
As per the patient, “It started as little itchy pimple,” 
then it became an ulcer 
The prostate was enlarged (I+) 
Stools guaiac, negative 
The patient was alert, fully oriented, with no 
meningismus or focal neurologic deficit 
DIAGNOSIS 
1. 
2. 
3. 
4. 
5. 
What is the differential diagnosis? 
Tuberculosis (TB) 
Syphilis 
Herpes simplex infection 
Aspergillosis 
Pneumocystis carinii pneumonia (PCP) 
Wberculosis 
Incorrect. However, this is a reasonable suggestion in this 
chronically ill New York City resident with AIDS and a his- 
tory of weight loss, low-grade fever, drenching night sweats, 
productive cough. As published by Pitchenick and others, 
the chest radiograph may be atypical or even normal in 
such profoundly immunosuppressed individuals with pul- 
monary TB. Instead, the radiographic pattern of this patient 
is consistent with congestive changes. Nonetheless, it is 
reasonable to place such a high-risk patient on acid-fast 
bacilli (AFB) isolation while pursuing appropriate investi- 
gations. Empirical antituberculous therapy is recommended 
as soon as sputum collection is complete. 
Syphilis 
Correct. Syphilis has been called “the great mimicker.” 
The chancre of primary syphilis is usually indurated, a 
finding not seen here. A darkheld test would have been 
appropriate, but it is not routinely available. The rapid 
plasma reagin (RPR) test was reactive at 1:4 and con- 
firmed by a positive fluorescent treponemal antibody 
absorption (FTA-ABS) test. The patient was treated with 
penicillin, but syphilis alone cannot explain the entire 
clinical presentation. As in many similar cases, this patient 
probably had more than one disease simultaneously; 
therefore, further investigations were warranted. 
Herpes Simplex 
Incorrect. Indeed, the penile lesion is compatible with 
herpes simplex virus (HSV) genitalis. The patient was 
started empirically on acyclovir. Again, this constellation 
of symptoms cannot be attributed to HSV alone, unless 
it is disseminated. 
Aspergillosis 
Incorrect. Invasive pulmonary aspergillosis is usually a 
late manifestation of AIDS in patients with CD4 cell count 
less than 5O/pL. It can present with cough, fever, and 
weight loss. A prominent feature is chest pain, which can 
be refractory, troublesome, and associated with hemopt- 
ysis. Pulmonary aspergillosis can present as invasive 
parenchymal, endobronchial, or intracavitary disease. In 
patients with AIDS, more than one pathologic type can 
be recovered on autopsy. Generally, lifelong suppressive 
therapy is indicated. 
Pneumocystis carhit Pneumonia 
Incorrect. The clinical presentation and the arterial blood 
gas support the diagnosis of severe PCP and justify empir- 
ical treatment. However, PCP by itself would rarely cause 
drenching night sweats and pleuritic chest pain. Car- 
diomegaly is not a feature of PCI? 
CLINICAL COURSE 
The patient was treated empirically with intravenous 
trimethoprim-sulfamethoxazole, penicillin, and acyclovir. 
However, he spiked fever to 1OO”E 102”E and 104°F on 
day 2,3, and 4, respectively. On day 4, he became lethar- 
gic, confused, and disoriented. An emergent lumbar punc- 
ture was done. Cerebrospinal fluid (CSF) was cloudy, 
colorless, with opening pressure of 15 cm H,O, WBC 50 
X 106/L, neutrophils 51%, lymphocytes 48%, eosinophils 
l%, red blood cell count (RBC) 10,450 X 106/L, protein 
0.46 g/L, glucose 5.77 mmol/L. Venereal Disease Research 
Laboratory (VDRL) test and AFB smear were negative. 
India ink was positive; CSF cryptococcal antigen (Ag)- 
reactive, 1:512. 
Laboratory tests included culture: Cvyptococcus neo- 
formans; and Gram stain: few neutrophils, no organisms. 
Head computed tomography (CT) without contrast 
(creatinine 205.87n.mol/dL): mild to moderate atrophy, 
no focal intracranial lesion. 
Four sputum samples were AFB-negative. Ampho- 
tericin B and isoniazid (INH), rifampin, pyrazinamide 
(PZA), and ethambutol were initiated, oral acyclovir and 
intramuscular weekly penicillin continued. 
On the ninth hospital day, a noncontrast chest CT 
revealed massive pericardial effusion (Figure 2A and B); 
at that time, the patient was asymptomatic; EKG was not 
consistent with tamponade. 
Two weeks after admission, the patient went into 
acute respiratory distress and was intubated and trans- 
ferred to the intensive care unit gCU) (Figure 3). Broad 
spectrum antimicrobials were added. Echocardiogram 
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Figure 1. Cardiomegaly, bilateral infiltrates, nodular densities. 
confirmed massive pericardial effusion without tampon- 
ade. But 5 days later, the patient developed tamponade 
and underwent emergent pericardiocentesis, which 
yielded 1000 cc of serosanguinous fluid, few WBCs, and 
no organisms; culture and cytology were negative. A peri- 
cardial window was performed after 24 hours. 
Histopathology demonstrated acute and chronic peri- 
carditis, absence of granuloma, and negative AFB and sil- 
ver stains. After 10 days in the ICU, the patient was 
Figure 2. Chest CT scans; A, cardiomegaly; f3, cardiomegaly, bilateral 
pulmonary nodules. 
Figure 3. Chest radiograph depicts diffuse bilateral pulmonary infil- 
trates in acute respiratory distress syndrome. 
extubated and transferred to the medical service. One 
week later, the patient again went into acute respiratory 
distress, and he was reintubated. Chest radiograph 
revealed diffuse pulmonary densities from hilum toward 
the periphery (Figure 3). Arterial blood gases on 2 L 0,: 
pH 7.31; PO, = 8.26 kPa; Pco, = 3.59 kPa; oxygen satu- 
ration = 88.8%; Co, = 15.5 mmol/L. 
Spinal tap was repeated and showed CSF was clear, 
colorless, with opening pressure of 12 cm H,O, WBC 1 
X lo’& RBC 17 X 106/L, protein 0.26 g/L, glucose 3.21 
mmol/L, India ink and cultures negative. The patient’s 
clinical condition continued to deteriorate, and he died 
1 week later. Acyclovir was continued during the entire 
hospitalization After 1 week of treatment, the penile ulcer 
regressed by about 5 to lo%, then it remained unchanged. 
MAJOR AUTOPSY FINDINGS 
Findings on autopsy included the following: 
. Systemic Kaposi’s sarcoma (KS), involving heart (Fig- 
ure 4) lungs 0;igure 5) liver, small intestine (Figure 
Figure 4. Kaposi’s sarcoma involving the heart (macroscopy) 
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Figure 5. A, Pulmonary Kaposi’s sarcoma (macroscopy); 6, Pul- 
monary Kaposi’s sarcoma (microscopy). 
6), kidneys (Figure 7) bladder, penis (Pigure S), lymph 
nodes, thyroid, right adrenal gland, soft tissue of the 
pelvis, mediastinum and retroperitoneum. 
Cytomegalovirus gastritis and adrenalitis 
Cryptococcal meningoencephalitis and lymphadenitis 
HIV encephalopathy 
HIV cardiomyopathy with cardiomegaly (600 g) and 
four chamber dilatation 
Lymphoid depletion, splenic and lymphatic 
Pleural effusion, serosanguinous, 1000 mL each cav- 
ity 
Pericardial effusion, serofibrinous, 90 mL 
Peritoneal effusion, serosanguinous, 500 mL 
DISCUSSION 
This report describes a case of unrecognized dissemi- 
nated KS in a patient with AIDS, a former injecting drug 
user. The sole mucocutaneous lesion was a shallow ulcer 
of the penis closely resembling a typical herpetic lesion. 
Systemic manifestations of KS were those of cardiac tam- 
ponade, rapidly progressive pulmonary infiltrates and 
pleural effusions in the setting of an acute opportunistic 
infection, and cryptococcal meningitis. 
Figure 6. Kaposi’s sarcoma of small bowel (macroscopy). 
Kaposi’s sarcoma is an angioproliferative disease char- 
acterized by interweaving bands of spindle cells, with 
irregular slit-like vascular channels, within a network of 
reticular and collagen fibers.’ Similar histologic features 
are encountered in the different forms of KS (i.e., classic, 
endemic, and epidemic KS). Moritz Kaposi originally 
described classic Kaposi’s sarcoma in 1872. This is usu- 
ally a mild disease affecting predominantly elderly men 
of Ashkenazi Jewish descent or from Mediterranean areas. 
It usually involves the lower extremities. Endemic KS 
affects men and women equally and also children in equa- 
torial Africa.* Kaposi’s sarcoma has also been recognized 
in HIV seronegative immunosuppressed individuals. Once 
the immunosuppressive therapy is removed, spontaneous 
resolution has been observed in 50% of cases.3 Kaposi’s 
sarcoma can appear at any stage of HIV infection. In the 
presence of an acute opportunistic infection, lower CD4 
cell count, and B symptoms, it follows a more rapid 
course.* The role of several cytokines in the pathogene- 
sis of KS has been elucidated; IL-6 seems to be predom- 
inant, for providing the pathway for tumor necrosis factor 
(TNF) and IL-1 to exert their activity.5 Researchers at the 
National Cancer Institute have established that HIV-1 Tat 
protein enhances endothelial cell growth and type IV 
collagenase expression in response to basic fibroblast 
growth factor, mimicking extracellular matrix protein.” 
But a subsequent report of KS in HIV-seronegative homo- 
sexual men casts a shadow on this assertion and rein- 
forces the notion of sexual transmission of KS by an 
infectious agent other than HIV.’ 
The etiology of KS has elluded scientists for many 
years. However, since the dawn of the AIDS epidemics, 
questions have been raised concerning the possibility of 
a sexually transmitted agent, because 
1. Among HIV-infected individuals, KS is much more 
prevalent in homosexual and bisexual men than in 
hemophiliacs, injecting drug users, and women8 
2. Among homosexual men, the prevalence of KS 
increases with the frequency of multiple sexual part- 
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Figure 7. Kaposi’s sarcoma of the kidney (microscopy). Figure 8. Ulcerative Kaposi’s sarcoma lesion of penis (microscopy). 
ners, and of anal-oral contact; KS is also associated 
with receptive anal intercourse.’ 
3. Women with KS tend to have a higher proportion 
of bisexual partners who also have KS.‘” 
In December of 1994, Chang and colleagues shed 
light on the mysteries of KS.” Using representational dif- 
ference analysis, they discovered the unique DNA 
sequences of a novel herpesvirus (Kaposi’s sarcoma-asso- 
ciated herpesvirus [KSHVj), closely related to the Gamma- 
herpesvirinae, herpesvirus saimiri, and Epstein-Barr virus, 
in more than 90% of KS tissues collected from patients 
with AIDS.” In less than a year, they and others identi- 
fied DNA sequences of KSHV in classic and endemic KS 
and also in KS that occurs in HIV-negative homosexual 
rnen.12,13 A study by Whitby and co-workers supports the 
causative role of KSHV in KS.‘* Their theory was sup- 
ported by the isolation of KSHV in spindle and endothe- 
ha1 cells, cell types thought to be neoplastic in these 
lesions.‘s A system for the lytic growth of the virus in a 
latently infected B-cell line was developed by scientists 
at the University of California at San Francisco which 
allowed them to first visualize the ultrastructure of the 
virus.‘” 
Despite their variation in pigmentation, size, shape, 
and distribution, the mucocutaneous lesions of KS are 
usually not difficult to recognize. They can be brownish 
or black in dark-skinned individuals and pink to purplish, 
or brown, in light-skinned individuals. They may be flat, 
raised, nodular, exophytic, and rarely, subcutaneous.” They 
arise predominantly in the oral cavity, the periauricular 
and periorbital areas, the ears, the lower extremities, the 
genitals, and the chest. Almost any part of the body has 
been involved, including many organs (e.g., bronchopul- 
monary tree, the gastrointestinal tract, the heart, and the 
bone marrow). Genital KS lesions are rarely ulcerated, 
except in the presence of edema after radiotherapy of 
lower extremities or secondary infection. Most visceral KS 
lesions remain asymptomatic. The clinical manifestations 
are nonspecific. Pulmonary KS can present as a chronic 
insidious illness characterized by frequent bouts of res- 
piratory ailments. Symptoms including dry cough, chest 
pain, hemoptysis, and fever have been reported. Wheez- 
ing can ensue when endobronchial lesions are signifi- 
cant. Pleuritic chest pain may be caused by pleural 
effusion, which may not be apparent on chest radiograph. 
In fact, chest radiograph may be normal in 5 to 20% of 
the cases,‘* but typical findings are perihilar infiltrates 
following the septal lines, and nodular opacities that may 
coalesce and progress rapidly in the setting of an acute 
opportunistic infection. I9 The final diagnosis relies on 
histopathologic examination of biopsy samples. Recently, 
a less invasive approach using a nested polymerase chain 
reaction (PCR) has been reported by Cathomas and col- 
leagues.“’ They isolated human herpesvirus (HHV)-S DNA 
in the bronchoalveolar lavage fluid of patients with pul- 
monary KS. If further studies confirm the diagnostic value 
of this technique, it may obviate the need for a trans- 
bronchial biopsy. A screening test, which detects anti- 
body to a latency-associated nuclear antigen (LANA), has 
been developed. Published results have shown a strong 
correlation between anti-LANA reactivity and the risk of 
KS.” Cardiomegaly due to heart involvement by KS is 
sometimes apparent on chest radiograph, especially when 
it is associated with pericardial effusion, which may lead 
to cardiac tamponade. In other patients seen at Harlem 
Hospital Center an epicardial surface studded with pur- 
ple or red nodules of KS has been revealed during peri- 
cardial window (Unpublished data). 
Chemotherapy may be effective in improving symp- 
toms, inducing tumor regression, and reducing edema. 
Monotherapy and various combination regimens as well 
as radiotherapy have been used.” Newer modalities of 
therapy undergoing clinical trials include liposomal anthra- 
cyclines, campthothecins, a novel class of drugs that are 
both antineoplastic and antiviral, and IL-4, an antagonist of 
IL-6 In particular, a large phase III trial has shown similar 
efficacy between liposomal daunorubicin and Adriamycin 
(doxorubicin), bleomycin, and vinblastine (ABV). Response 
rates, time to treatment failure, and overall survival were 
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not significantly different. ‘j Whatever the therapeutic 
agents chosen, antiretroviral therapy, prophylaxis for 
opportunistic infections, and the use of hematopoietic 
growth factors should be routinely included in the man- 
agement of these patients. There have been anecdotal 
reports of regression of AIDS-related KS lesions and clear- 
ance of HHV-8 from peripheral blood mononuclear cells 
following treatment with an HIV-1 protease inhibitor.24.25 
However, at present, the impact of protease inhibitors on 
the incidence and treatment of KS is undetermined. 
Researchers at Lee Moffitt Cancer Center in Florida devel- 
oped an antiviral drug assay using lytic KSHV DNA syn- 
thesis induction by the phorbol ester 12-0-tetmdecanoyl 
phorbol-13-acetate (TPA) in BCBL-1 cells. This assay was 
useful to obtain accurate 50% inhibitory concentration 
(lC,$ values. It was determined that KSHV is sensitive to 
cidofovir, moderately sensitive to phosphonoformic acid, 
and ganciclovir, and weakly sensitive to acyclovir.2G Neyts 
and De Clercq examined the concentrations required to 
reduce HHV-8 DNA synthesis in TPA-stimulated BCBL-1 
cells 8. S2242, a novel nucleoside analogue, with broad- 
spectrum activity against all herpesviruses, including 
thymidine kinase (TK)-deficient strains, exerted the most 
potent inhibition. It was followed by adefovir, a compound 
with anti-HIV-l activity (90% effective concentration 
[EC,], 0.6 + 0.5 FM) and cidofovir (EC,, 18 ? 9 PM), 
which has long-lasting inhibition of KSHV replication. The 
50% effective concentration (ECJ of foscarnet was four- 
fold higher than that of adefovir (177 FM and 39 PM, 
respectively).27 These experiments may open the door of 
antiviral trials for KSHV 
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